Meat mineral content in broilers fed diets without mineral and vitamin supplements

Este estudo teve como objetivo verificar o efeito da retirada do suplemento de minerais e vitaminas (MVS) da dieta sobre o conteúdo de minerais na carne de frango. As aves receberam os seguintes tratamentos alimentares: dieta-controle contendo MVS de 21 a 42 dias; dieta sem MVS de 21 a 42 dias; dieta sem MVS de 28 a 42 dias; dieta sem MVS de 35 a 42 dias. A composição mineral foi analisada na carne branca e escura de machos e fêmeas. O nível de Ca foi mais baixo na carne das aves alimentadas com dietas sem MVS de 21 a 42 dias do que nas dos demais tratamentos. O conteúdo de potássio foi mais elevado na carne das aves em que o MVS foi retirado no período de 38 a 42 dias que na das aves dos demais tratamentos. A retirada do MVS não afetou os níveis de Na, Fe, Zn e Mn das carnes. As fêmeas apresentaram carne com teores mais altos de K e Fe que os machos. A carne escura dos frangos mostrou níveis mais altos de Ca, Na, Fe e Zn e mais baixos de P, Mg e K do que a carne branca.A study was conducted to verify the effect of trace mineral and vitamin supplement (MVS) withdrawal from the diet of broilers on meat mineral content. Birds received the following feed treatments: control diet with MVS from day 21 to day 42; diet without MVS from day 21 to day 42; diet without MVS from day 28 to day 42 and diet without MVS from day 35 to day 42. Mineral composition was assessed in light and dark meat from male and female birds. Calcium level was lower in meat from birds fed diet without MVS from day 21 to day 42 as compared to the other treatments. Potassium level was higher in meat from birds fed diet without MVS from day 28 to day 42 than in that from other treatments. Removal of dietary MVS did not affect the meat levels of Na, Fe, Zn and Mn. The meat from female birds showed higher contents of K and Fe than that from male birds. Dark meat was found higher in Ca, Na, Fe and Zn contents and lower in P, Mg and K levels than light meat

Yolk fatty acids and egg components from layers fed diets with coconut meal

O objetivo deste trabalho foi avaliar o efeito da inclusão do farelo de coco (FC) na ração e do tempo de alimentação de poedeiras comerciais, sobre os ácidos graxos da gema e os componentes do ovo. O delineamento foi em esquema fatorial 5x2, com cinco níveis de inclusão do FC (0, 5, 10, 15 e 20%) e dois tempos de alimentação (14 e 28 dias). Foram avaliados o peso e as porcentagens de albúmen, gema e casca dos ovos, bem como os sólidos e lipídios totais e o perfil de ácidos graxos das gemas. A inclusão do FC e o tempo de alimentação influenciaram apenas a proporção de ácido mirístico na gema, que aumentou com a inclusão do FC aos 28 dias de alimentação. Os ácidos esteárico e oléico variaram somente com o tempo de alimentação, e as maiores concentrações foram obtidas aos 28 dias. A relação de ácidos graxos poliinsaturados para ácidos graxos saturados da gema diminuiu a partir de 10% de inclusão e aumentou com o tempo de alimentação das aves. O uso de farelo de coco, na ração de poedeiras comerciais, não influencia a proporção dos componentes do ovo, apenas altera a concentração do ácido mirístico da gema.The objective of this work was to evaluate the effects of coconut meal (CM) inclusion in commercial layer diets and feeding time, on egg components and yolk fatty acid composition. The experiment followed a factorial design 5x2, with five levels of CM inclusion (0, 5, 10, 15 and 20%) and two feeding time (14 and 28 days). Parameters evaluated included: egg weight, and albumen, yolk and shell percentages, as well as solids, lipids and fatty acid profile of the yolk. The inclusion of CM and feeding time affected the yolk content of myristic acid which increased with CM level and with feeding time. The levels of stearic and oleic acids in the yolk varied with feeding time and were higher in the eggs after 28 days. Polyunsaturated to saturated fatty acid ratio in yolk decreased, when dietary CM levels were higher than 10%, and increased with longer feeding time. The use of CM in laying hen diets does not influence egg composition but increases myristic acid content of the yolk

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters. Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs). Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001). Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio

Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world. Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231. Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001). Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication

4to. Congreso Internacional de Ciencia, Tecnología e Innovación para la Sociedad. Memoria académica

Este volumen acoge la memoria académica de la Cuarta edición del Congreso Internacional de Ciencia, Tecnología e Innovación para la Sociedad, CITIS 2017, desarrollado entre el 29 de noviembre y el 1 de diciembre de 2017 y organizado por la Universidad Politécnica Salesiana (UPS) en su sede de Guayaquil. El Congreso ofreció un espacio para la presentación, difusión e intercambio de importantes investigaciones nacionales e internacionales ante la comunidad universitaria que se dio cita en el encuentro. El uso de herramientas tecnológicas para la gestión de los trabajos de investigación como la plataforma Open Conference Systems y la web de presentación del Congreso http://citis.blog.ups.edu.ec/, hicieron de CITIS 2017 un verdadero referente entre los congresos que se desarrollaron en el país. La preocupación de nuestra Universidad, de presentar espacios que ayuden a generar nuevos y mejores cambios en la dimensión humana y social de nuestro entorno, hace que se persiga en cada edición del evento la presentación de trabajos con calidad creciente en cuanto a su producción científica. Quienes estuvimos al frente de la organización, dejamos plasmado en estas memorias académicas el intenso y prolífico trabajo de los días de realización del Congreso Internacional de Ciencia, Tecnología e Innovación para la Sociedad al alcance de todos y todas